UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

Psychopharmacologia, 1989, Vol.99 Suppl (S1), p.S28-S31

1989

Volltextzugriff (PDF)

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

EUROPEAN PSYCHIATRY, 2007, Vol.22, p.S5-S6

2007

Volltextzugriff (PDF)

Characterization of dopamine receptor binding sites in the subthalamic nucleus

Neuroreport, 1994-09, Vol.5 (14), p.1836-1838

1994

Volltextzugriff (PDF)

Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain

Neuroscience, 1994-12, Vol.63 (4), p.1003-1020

1994

Volltextzugriff (PDF)

Tyrosine transport is regulated differently in patients with schizophrenia

Schizophrenia research, 1999-11, Vol.40 (1), p.37-42

1999

Volltextzugriff (PDF)

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Psychopharmacology, 1995-10, Vol.121 (3), p.309-316

1995

Volltextzugriff (PDF)

Functional characterization of tyrosine transport in fibroblast cells from healthy controls

Neuroscience letters, 2008, Vol.434 (1), p.56-60

2008

Volltextzugriff (PDF)

Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia

Prostaglandins, leukotrienes and essential fatty acids, 1996-08, Vol.55 (1), p.55-58

1996

Volltextzugriff (PDF)

Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol

Synapse (New York, N.Y.), 1999-12, Vol.34 (3), p.192-207

1999

Volltextzugriff (PDF)

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Life sciences (1973), 1987-12, Vol.41 (25), p.2749-2757

1987

Volltextzugriff (PDF)

Neuroleptic Treatment of Patients with Schizophrenia Mechanisms of Action and Clinical Significance

British journal of psychiatry, 1994-04, Vol.164 (S23), p.65-70

Wiesel, Frits-axel

1994

Volltextzugriff (PDF)

Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose

Journal of cerebral blood flow and metabolism, 1990-07, Vol.10 (4), p.467-483

1990

Volltextzugriff (PDF)

Metabolic approaches to physiologic subtyping of schizophrenia

Clinical neuropharmacology, 1992, Vol.15 Suppl 1 Pt A, p.26A-27A

Wiesel, F A

1992

Volltextzugriff (PDF)

Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?

Journal of neural transmission. Supplementum, 1992, Vol.37, p.1

Wiesel, F A

1992

Volltextzugriff (PDF)

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Acta psychiatrica Scandinavica, 1989-08, Vol.80 (S352), p.30-34

1989

Volltextzugriff (PDF)

Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment

Progress in Neuropsychopharmacology & Biological Psychiatry, 1992, Vol.16 (6), p.871-881

Wiesel, Frits-Axel

1992

Volltextzugriff (PDF)

The Need of Support and Service Questionnaire (NSSQ): A brief scale to assess needs in clients with long-term mental disabilities

Nordic journal of psychiatry, 2005, Vol.59 (6), p.465-472

2005

Volltextzugriff (PDF)

Neuroleptics and diagnostic heterogeneity in relation to drug evaluation

Psychopharmacology series, 1993, Vol.10, p.124

Wiesel, F A

1993

Volltextzugriff (PDF)

PET studies of dopamine receptors in relation to antipsychotic drug treatment

Clinical neuropharmacology, 1992, Vol.15 Suppl 1 Pt A, p.468A-469A

1992

Volltextzugriff (PDF)

Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients

Life sciences (1973), 1987-08, Vol.41 (7), p.813-816

1987

Volltextzugriff (PDF)

Determination of conjugated monoamine metabolites in brain tissue

Journal of Neural Transmission, 1976-12, Vol.39 (4), p.281-290

1976

Volltextzugriff (PDF)

Schizophrenia as a systemic disorder — studies of peripheral and central biological functions

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.219-219

2002

Volltextzugriff (PDF)

Muscle histopathology in schizophrenia

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.45-45

2002

Volltextzugriff (PDF)

Aberrant tyrosine transport across the cell membrane in schizophrenia

EUROPEAN PSYCHIATRY, 2002, Vol.17, p.75-75

2002

Volltextzugriff (PDF)

The significance of the D2 dopamine receptor in schizophrenia as studied with PET

Clinical neuropharmacology, 1992, Vol.15 Suppl 1 Pt A, p.460A-461A

Wiesel, F A

1992

Volltextzugriff (PDF)

1 – 25 von 284

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(199)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

The complexity of using D2-dopamine antagonists in the treatment of patients with schizophrenia

Characterization of dopamine receptor binding sites in the subthalamic nucleus

Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain

Tyrosine transport is regulated differently in patients with schizophrenia

Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients

Functional characterization of tyrosine transport in fibroblast cells from healthy controls

Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia

Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Neuroleptic Treatment of Patients with Schizophrenia Mechanisms of Action and Clinical Significance

Positron emission tomographic measurements of cerebral glucose utilization using [1-11C]D-glucose

Metabolic approaches to physiologic subtyping of schizophrenia

Glucose metabolism in psychiatric disorders: how can we facilitate comparisons among studies?

Clinical melperone treatment blocks D2-dopamine receptors in the human brain as determined by PET

Regional glucose metabolism in schizophrenic patients before and during neuroleptic treatment

The Need of Support and Service Questionnaire (NSSQ): A brief scale to assess needs in clients with long-term mental disabilities

Neuroleptics and diagnostic heterogeneity in relation to drug evaluation

PET studies of dopamine receptors in relation to antipsychotic drug treatment

Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients

Determination of conjugated monoamine metabolites in brain tissue

Schizophrenia as a systemic disorder — studies of peripheral and central biological functions

Muscle histopathology in schizophrenia

Aberrant tyrosine transport across the cell membrane in schizophrenia

The significance of the D2 dopamine receptor in schizophrenia as studied with PET

Aktive Filter

Suchergebnisse filtern